Delivery Order SPE2DB22D3009-SPE2DB25FAP59
Award Date
1/24/25
Potential Completion Date
1/27/25
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,962.53. The contract is for the supply of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $7,753.70 and a completion date of February 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen also holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,562,473,545 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a total ceiling value of $14,200.58 and is a firm fixed-price contract with an ultimate completion date of October 16, 2023. The contract is not designated...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,958,111 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and a total ceiling value of $17,185.18. It is not set aside for any specific type of business. The contract has an ultimate...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 8 mg Ondansetron hydrochloride tablets, used to treat nausea and vomiting, with a ceiling value of $5,665.56 and a completion date of January 20, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $6,368.67 and a completion date of January 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $13,937.41 and a completion date of February 20, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $6,007.11 and an ultimate completion date of May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor and is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $8,204.58 and runs through March 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...